findmyKOL

Robert Toto, MD

Enriched profile

Mary M. Conroy Professor of Kidney Disease, Department of Internal Medicine; Distinguished Teaching Professor; Associate Dean of Clinical and Translational Research, Graduate School of Biomedical Sciences · The University of Texas Southwestern Medical Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Dallas, TX · South Central · United StatesSpecialtyNephrologyFocusChronic Kidney Disease and Diabetes+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1986–2026

Robert Toto is Mary M. Conroy Professor of Kidney Disease, Department of Internal Medicine; Distinguished Teaching Professor; Associate Dean of Clinical and Translational Research, Graduate School of Biomedical Sciences at The University of Texas Southwestern Medical Center. OpenAlex indexes 390 publications with 33,663 citations (h-index 81); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Robert Toto, MD, is Mary M. Conroy Professor of Kidney Disease, Department of Internal Medicine at The University of Texas Southwestern Medical Center. The public record shows 390 publications with 33,663 citations (h-index 81), centered on Chronic Kidney Disease and Diabetes, Diabetes Treatment and Management, Blood Pressure and Hypertension Studies. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 14 companies, 22 NIH-funded awards (1986–2026).

  • Most recent indexed publication: 2026 · Kidney360
  • Top research focus: Chronic Kidney Disease and Diabetes
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 14 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Chronic Kidney Disease2 trialsHypertension2 trialsAcute Kidney Injury2 trialsRenal Insufficiency2 trialsType 2 Diabetes1 trialType 1 Diabetes1 trialRenal Insufficiency, Chronic1 trialESRD / Dialysis

Research focus

OpenAlex concept fingerprint
Chronic Kidney Disease and DiabetesDiabetes Treatment and ManagementBlood Pressure and Hypertension StudiesDialysis and Renal Disease ManagementRenal Diseases and Glomerulopathies

Drugs & molecules

across trials, industry payments and publications
Farxigageneric · DapagliflozinClinical trials—Industry payments1Publications10Aranespgeneric · Darbepoetin alfaClinical trials—Industry payments6Publications2Tradjentageneric · LinagliptinClinical trials—Industry payments2Publications1Kerendiageneric · FinerenoneClinical trials—Industry payments1Publications1Lokelmageneric · Sodium zirconium cyclosilicateClinical trials—Industry payments6Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments2Publications—Tarpeyogeneric · BudesonideClinical trials—Industry payments2Publications—Parsabivgeneric · EtelcalcetideClinical trials—Industry payments1Publications—Veltassageneric · PatiromerClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
AstraZeneca UK LimitedClinical trials—Industry payments12Amgen Inc.Clinical trials—Industry payments8AstraZeneca Pharmaceuticals LPClinical trials—Industry payments6Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments4Novo Nordisk ASClinical trials—Industry payments3Boehringer Ingelheim International GmbHClinical trials—Industry payments2Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments2Calliditas Therapeutics US Inc.Clinical trials—Industry payments2Lilly USA, LLCClinical trials—Industry payments2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Clinical trials2Industry payments—Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trials—Industry payments2University of Texas Southwestern Medical CenterClinical trials2Industry payments—Vifor Pharma, Inc.Clinical trials—Industry payments2Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments1Eli Lilly and CompanyClinical trials—Industry payments1Icahn School of Medicine at Mount SinaiClinical trials1Industry payments—Novo Nordisk IncClinical trials—Industry payments1University of TexasClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
390publications

Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.

33,663citations

Total citations across indexed works.

81h-index

Hirsch index (OpenAlex). i10-index 222.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
14companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
22NIH grants · 1986–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    70.4%
    Angiotensin receptor blocker (ARB)31.8%
    Losartan Potassium60%Telmisartan40%
    Part D<11 patients
    Loop diuretic12.8%
    Torsemide100%
    Part D≥12 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    29.6%
    SGLT2 inhibitor15.6%
    Farxiga100%
    Part D<11 patients
    Vitamin D3 Analog7.8%
    Calcitriol100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

22 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:

Congress activity

Updated 14 Oct 2026

6 congress contributions (2019–2022) across ADA, ENDO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Hiddo J.L. Heerspink72Glenn M. Chertow71John J.V. McMurray70Peter Rossing70Anna Maria Langkilde55David C. Wheeler53Niels Jongs51Ricardo Correa‐Rotter47C. David Sjöström42Bergur V. Stefánsson42Tom Greene37Priya Vart30Fan Fan Hou27Orson W. Moe25Giuseppe Remuzzi25Vlado Perkovic25Christoph Wanner25Javier A. Neyra23Mark E. Cooper22George L. Bakris20Andrew S. Levey18Dick de Zeeuw18Darren K. McGuire18Odd Erik Johansen15Sven Schnaidt15Julio Rosenstock15Julia B. Lewis15Nikolaus Marx14Scott D. Solomon14John H. Alexander14Steven E. Kahn13Beverley Adams‐Huet13Bernard Zinman13Xilong Li13Jyothis T. George12Jula K. Inrig12Ricardo Correa-Rotter12Ajay Singh12Egon Pfarr12Victor Ortiz-Soriano11

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/robert-toto-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    pmc.ncbi.nlm.nih.gov/articles/PMC9076781

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Editorial board member

    Kidney International

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →utswmed.org ↗
  • Editorial board member

    Journal of the American Society of Nephrology (JASN)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →utswmed.org ↗
  • Editorial board member

    American Journal of Kidney Disease and Nephrology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →utswmed.org ↗
  • Editorial board member

    Nephrology Dialysis and Transplantation

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →utswmed.org ↗
  • Editorial board member

    Current Opinion in Nephrology and Hypertension

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →utswmed.org ↗
  • Member

    American Society of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • Member

    American Heart Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • Member

    National Kidney Foundation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • Member

    Renal Physicians Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • Fellow

    American College of Physicians

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pub.orcid.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.